New partnership launched to accelerate the elimination of relapsing P. vivax malaria
Recently, the Partnership for Vivax Elimination (PAVE) was formed to support malaria endemic countries in their quest to eliminate Plasmodium vivax (P. vivax). This partnership is critical because more than one-third of the world’s population is at risk of contracting P. vivax and it is the most common form of malaria outside of sub-Saharan Africa. Young children and pregnant women are impacted the most. P. vivax constitutes a major challenge in eliminating malaria because hypnozoites, … Continued
